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Nonsyndromic hearing loss is a paradigm of genetic heterogeneity with 85 loci and 39 nuclear disease genes reported so far.
Mutations of BSND have been shown to cause Bartter syndrome type IV, characterized by signiﬁcant renal abnormalities
and deafness and nonsyndromic nearing loss. We studied a Pakistani consanguineous family. Clinical examinations of aﬀected
individuals did not reveal the presence of any associated signs, which are hallmarks of the Bartter syndrome type IV. Linkage
analysis identiﬁed an area of 18.36Mb shared by all aﬀected individuals between markers D1S2706 and D1S1596. A maximum
two-point LOD score of 2.55 with markers D1S2700 and multipoint LOD score of 3.42 with marker D1S1661 were obtained.
BSND mutation, that is, p.I12T, cosegregated in all extant members of our pedigree. BSND mutations can cause nonsyndromic
hearing loss, and it is a second report for this mutation. The respected protein, that is, BSND, was ﬁrst modeled, and then, the
identiﬁed mutation was further analyzed by using diﬀerent bioinformatics tools; ﬁnally, this protein and its mutant was docked
with CLCNKB and REN, interactions of BSND, respectively.
1.Introduction
Deafness or hearing loss can be due to genetic or environ-
mental causes or a combination of both. The genetic hearing
loss is classiﬁed as syndromic or nonsyndromic. Among
the many disorders classiﬁed as syndromic hearing loss,
the pathology varies widely, but in nonsyndromic hearing
loss, the defect is generally sensorineural. Seventy percent of
deafnesshasgeneticcausesandisclassiﬁedasnonsyndromic.
Autosomal recessive nonsyndromic deafness is genetically
heterogeneous and is the most common form of inherited
hearing loss. Autosomal recessive genes are responsible for
about77%ofthecasesofhereditarynonsyndromicdeafness,
with over 85 loci and 21 diﬀerent genes identiﬁed to
date (http://hereditaryhearingloss.org/) .T h eh i g hd e g r e eo f
genetic heterogeneity of deafness reﬂects the great diversity
of specialized proteins that are required to make sense
of sound, and continuing discovery of common and rare
mutations associated with deafness in humans has provided
many serendipitous points of entry into the biology of
hearing.
Bartter’s syndrome (BS) is characterized byhypokalemic,
hypochloremicmetabolicalkalosiswithnormalorlowblood
pressure despite high plasma renin activity and serum
aldosterone. The inheritance pattern is autosomal recessive.
Antenatal BS with bilateral sensorineural deafness (BSND)
was ﬁrst described in children born to a consanguineous
couple from a Bedouin family of Southern Israel [1]. BS
type IV, BSND variant, occurs because of a mutation in
the BSND gene on chromosome 1p31 coding for protein
“barttin” which forms the β subunit of CICKb and CICKa
channels located on the basolateral membrane of TAL and
inner ear epithelium [2]. The clinical features of Bartter syn-
drome type IV include sensorineural deafness and peculiar
facies, distinguished by the triangular face, large eyes, and
protruding ears (1).
Mutation in BSND gene is analyzed by model prediction
using SAM T08 server. Comparison of the protein sequence2 Journal of Biomedicine and Biotechnology
of BSND with closely related species takes place and ﬁnd
out conserved regions. Other bioinformatics analysis such as
protein modeling and proteins docking are also carried out
for more bioinformation.
2.MaterialsandMethods
Before the onset of the study, approval from the Insti-
tutional Review Board, Islamabad, and informed consent
was obtained from all individuals. Clinical examination was
performed at hospitals of the respective area. Audiometry
was performed on selected individuals to detect the level
of hearing loss. The families were visited at their places
of residence to generate pedigrees [3] and collect other
relevant information. Blood samples from available aﬀected
and normal individuals of each family were collected for
DNA extraction.
2.1. Genotyping and Linkage Studies. High molecular weight
DNA was extracted from leukocytes following the standard
method as described by Sambrook et al. [4]. Genomic DNA
was quantiﬁed by spectrophotometer readings at OD260 and
diluted to 40ng/uL for ampliﬁcation by polymerase chain
reaction (PCR).
To elucidate the gene defect in the family presented here,
an initial search for linkage was carried out by using poly-
morphic microsatellite markers mapped within autosomal
recessive nonsyndromic deafness loci listed on the hereditary
hearing loss homepage [5]. Genome-wide screening was
conductedwithmicrosatellitemarkers(LinkageMappingSet
10, Invitrogen, USA). Two-point linkage analysis was carried
out using MLINK of the FASTLINK computer package [6].
Multipoint linkage analysis was performed using ALLEGRO
[7]. For the analysis, an autosomal recessive mode of
inheritance with complete penetrance and a disease allele
frequency of 0.001 were assumed. Equal allele frequencies
were used in the analysis. However, since it is well known
that using allele frequencies, which are too low, can lead to
false positive results, a sensitivity analysis was performed.
Haplotypes were constructed using SIMWALK2 [8, 9].
2.2.MutationScreening. ToscreenformutationintheBSND
gene, exons and splice junction sites were PCR ampliﬁed
from genomic DNA using the four primer sets. The puriﬁed
PCR products were subjected to cycle sequencing using big
dye terminator V 3.1 ready reaction mix and sequencing
buﬀer (PE Applied Biosystems, Foster City, Calif, USA). The
sequencing products were puriﬁed to remove unincorpo-
rated nucleotides and primers with Centriﬂex TM Gel Filtra-
tion Cartridge (Edge Biosystems, Gaithersburg, Md, USA).
These puriﬁed products were resuspended in 10μLo fT S R
(Template Suppression Reagent) and were placed in 0.5mL
septa tubes to be directly sequenced in an ABI Prism 310
Automated Sequencer (PE Applied Biosystems, Foster City,
Calif, USA). Chromatograms from normal and aﬀectedindi-
viduals were compared with the corresponding control gene
sequences from NCBI (National Center for Biotechnology
Information) database to identify the aberrant nucleotide
base-pair change. (http://www.ncbi.nlm.nih.gov/).
2.3. Protein Modeling, Docking, and Phylogenetics Analysis.
SAM T08 [10–14] was used to model the BSND protein and
its interacting protein with highest conﬁdence score (i.e.,
0.990) CLCNKB. For their further evaluation, RAMPAGE
server [15] was considered. ClustalW program was subjected
to analyze the phylogenetics relationship of diﬀerent animals
havingBSNDprotein.Conservedaminoacidswerepredicted
by using UniportKB tool available on Expasy server.
Identiﬁed BSND mutation was generated by using Swis-
spdb server. Protein interactor of BSND was found out by
STRING server, an online database of known and predicted
protein interactions which includes direct (physical) and
indirect (functional) associations [16]. Protein docking of
boththenormalandthemutantBSNDwascarriedoutusing
HEX tool with its interactive proteins CLCNKB and REN.
3. Results
3.1. Clinical Assessments. Ages of aﬀected individuals varied
between 12 and 65 years at the time of study. Clinical exami-
nation of the hearing impaired individuals did not reveal the
presence of signs or symptoms, which are hallmarks of the
Bartter syndrome type IV. Urinary and blood biochemistry
was tested at the Islamabad Diagnostic Centre, including
testing for liver function, renal function, electrolytes, and
hematology. Blood hematology and biochemistry markers
were within the normal range, except that renin level was at
borderline in one of the aﬀected subject (VI: 5, 2.53mL/h).
Detailed clinical and biochemical features of normal and
aﬀected members are mentioned in Table 1. The height and
weight were within normal range for the local population.
An audiometric evaluation of selected aﬀected members by
measuring the threshold of hearing at 250–8000Hz for pure-
tune air conduction and bone conduction showed severe
hearing loss across all frequencies.
Renal sonography ruled out the presence of nephrocal-
cinosis or metabolic alkalosis in these aﬀected individuals.
Nor have the aﬀected individuals displayed problems with
polydipsia, polyuria, nocturnal enuresis, and hypocalciuria.
3.2. Genotyping Results. Analysis of the results obtained
from genome search performed on the ten individuals of
the family (III-1, III-3, IV-1, V-1, V-2, V-4, V-5, VI-1,
VI-3, and VI-5) (Figure 1) identiﬁed an area of interest on
chromosome 1. Two-point analysis generated LOD score
of 2.027 at marker D1S193 (73.21cm) and 2.05 at marker
D1S3462 (247.23cm) on chromosome 1 (Table 2). In order
to test linkage to these two regions, additional markers
located in the vicinity of D1S3462 and D1S193 were chosen
from Marshﬁeld map [17] and genotyped in all the ten
family members. The maximum two-point LOD score
was increased to 2.55 with marker D1S2700. Multipoint
linkage analysis for the family derived a maximum LOD
score of 3.42 at marker D1S1661 (Table 3). The three-unit
multipoint support interval contained a 10.48Mb region,
which span from markers D1S3721 to D1S2690. Haplotypes
analysis delimited the centromeric boundary deﬁned by
a recombination between markers D1S1596 and D1S2770Journal of Biomedicine and Biotechnology 3
Table 1: Clinical and biochemical features of normal and aﬀected members of studied family.
Features Reference ranges Normal members Aﬀected members from the family with hearing loss
V:3 V:5 V:1 VI:3 VI:5
Age (y) 30 35 45 12 10
O t h e rs y m p t o m so fB S I V n o n o N o N o N o
S
d·Na (mmol/L) 136–148 141 140 135 137 134
S·K (mmol/L) 3.6–5.0 3.9 4.6 3.4 3.5 3.5
S·Cl (mmol/L) 104–114 105 107 97 102 101
S·Mg (mg/dl) 1.9–2.5 2.3 2.2 2.0 1.9 2.1
S·HCO3 (mmol/L) 17.5–27.5 30.0 27.5 30.0 30.2 31.0
S·Ca (mg/dl) 8.6–10.5 8.7 9.5 9.2 9.8 10.0
S·Creatinine (mg/dL) 0.85–1.35 0.7 0.8 0.6 0.5 0.4
P
e Renin (ng/ml/hr) 0.15–2.33 0.31 0.6 2.13 2.03 2.53
S·Aldosterone (ng/dL) 1–6;f 4–31 >1.7f 13.0 10.3 11.9 6.3
S·Osmolality (mosm/kg) 275–295 293 289 281 290 287
U
g Na (mmol/L) 30–150 17.5 154.6 39.1 16.9 13.3
U·K (mmol/L) 20–67 3.4 91.31 12.13 8.43 4.12
U·Ca (mg/dL) 6.0 16.0 15.3 11.3 13.0
U·Mg (mg/dL) 3.6 14.4 3.1 2.4 1.12
U·Cl (mmol/L) 46–168 16.3 174.3 46.56 19.2 10.5
Uosmolality (mosm/kg) 50–1400 74 903 179 105 56
NephrocacinosisS Absent Absent Absent Absent Absent
in individual V-1. Recombination event between D1S2706
and D1S3721, deﬁned the telomeric boundary in the same
individual (V-1). Therefore, the minimum critical region
of 18.36Mb identiﬁed for disease locus and shared by all
the aﬀected individuals between the markers D1S2706 and
D1S1596. The critical interval (17.27cm) identiﬁed in this
Pakistani family overlaps with the critical region to which
DFNA2 was mapped on 1p34 in a large Indonesian family
with autosomal dominant, progressive and sensorineural
hearing loss [18]. The DFNA2 locus maps between markers
D1S255 (65.47cm) and D1S211 (73.81cm), and thus shares
a region of 2.68cm with DFNB interval identiﬁed in our
family.Riazuddinetal.[19]identiﬁed1.5Mbinfourkindred
segregating nonsyndromic deafness at the chromosome 1.
3.3. Mutation Analysis of Candidate Genes. Through a
database search, we identiﬁed several genes mapping
between the linkage interval in the family (Human Genome
Project-Santa Cruz; http://genome.ucsc.edu/, May 2004).
Among these, KCNQ4 (MIM 603537), CLDN19, FOXE3
(MIM601094),FOXD2(MIM602211),TSPAN1,andBSND
(MIM 606412) were plausible candidate candidates in the
interval of our family. We started sequencing of these and
completely sequenced two genes (KCNQ4 and CLDIN19),
but we found no mutation in both. Recent studies of
Riazuddin et al. [19] showed that mutation in BSND can
cause nonsyndromic deafness and is the molecular basis of
DFNB73 locus in four Pakistani families segregating non-
syndromic deafness [19]. As the critical interval identiﬁed in
the family contains potential candidate gene barttin (BSND,
MIM 606412) as well; therefore, it was sequenced to search
for the mutation. Sequence analysis of exon 1 of the BSND
gene in our family also revealed missense mutation involving
T to C transition at nucleotide number 35 (35T > C),
which resulted in substitution of isoleucine to threonine at
amino acid position 12 (I12T) (Figure 2). BSND mutation;
that is, p.I12T cosegregated in all extant members of the
pedigree.Thismutationwaspresentintheheterozygousstate
in obligate carriers within the family.
3.4. Bioinformatics Analysis. Models of BSND CLCNKB
and REN proteins were generated by SAM T08 server and
visualized by Rasmol (Figure 3(a)–3(c)). Rampage values for
BSND were number of residues in favored region 95.6%, the
number of residues in allowed region 3.1%, and the number
of residues in outlier region 1.4% (Figure 4(a)); however, the
CLCNKB and REN values were little varying. Its values were
the number of residues in favored region: 94.8%, 97%, the
number of residues in allowed region: 4.2%, 3%, and the
number of residues in outlier region is 0.9% for CLCNKB
a n d0 %f o rR E N( Figure 4(c)).
Comparison of conserved amino acid of human BSND
with closely related species like mouse, rat, and rabbit
shows that isoleucine at position 12 is highly conserved, so4 Journal of Biomedicine and Biotechnology
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Figure 1: Pedigree of family with nonsyndromic autosomal recessive hearing loss associated haplotypes. Haplotypes for the most closely
linked STRPs are shown below each symbol. The genetic map distances according to the Marshﬁeld genetic map in centimorgans (cM) are
shown in parenthesis next to the marker name. Arrows adjacent to the haplotypes indicate key recombination events. The alleles are denoted
1–3 according to their allele size.Journal of Biomedicine and Biotechnology 5
Table 2: Two-point LOD score results between the locus identiﬁed in family and chromosome 1p34.2–p32.1 markers.
Marker deCode map postion1 Marshﬁeld map postion2 Physical map postion3 LOD score AT θ =
0.00 0.01 0.05 0.1 0.2 0.3
D1S472 57.95 65.47 37,102,828 −999.99 −0.68 −0.05 0.14 0.20 0.13
D1S186 60.14 67.22 37,900,316 −999.99 −.069 −0.10 0.05 0.10 0.06
D1S432 — 69.86 39,046,164 −1.334 −0.69 −0.18 −0.02 0.03 0.01
D1S1598 63.51 70.41 40,011,183 −1.544 −0.61 −0.09 0.03 0.04 0.00
D1S2706 65.31 71.13 40,741,361 −999.99 −1.34 −0.18 015 0.24 0.14
D1S3721 65.87 72.59 41,395,560 2.027 1.97 1.75 1.49 1.49 0.56
D1S193 66.64 73.21 42,688,369 2.027 1.97 1.75 1.49 0.99 0.56
D1S2713 67.87 73.81 44,182,569 1.726 1.67 1.47 1.24 0.80 0.43
D1S2134 71.29 75.66 47,993,241 1.690 1.66 1.52 1.32 0.91 0.52
D1S1661 72.42 78.25 51,142,551 1.228 1.19 1.06 0.90 0.60 0.33
D1S2652 77.15 80.77 55,178,852 1.319 1.28 1.13 0.96 0.62 0.34
D1S2690 79.63 83.07 56,867,560 2.027 1.97 1.75 1.49 0.99 0.56
D1S2700 83.07 87.31 58,828,955 2.556 2.48 2.21 1.88 1.23 0.66
D1S2770 85.02 88.40 59,442,255 −999.99 −0.26 0.26 0.35 0.29 0.17
D1S1596 — 89.49 59,670,589 −1.55 −0.52 −0.00 0.10 0.08 0.01
D1S2737 85.47 90.58 61,038,037 −999.99 −1.10 0.07 0.40 0.46 0.29
D1S2788 87.25 93.86 61,568,857 −999.99 −2.16 −0.90 −0.46 −0.14 −0.03
D1S230 88.12 95.31 62,314,306 −999.99 −2.16 −0.90 −0.46 −0.14 −0.03
D1S1648 99.62 101.48 73,125,563 −999.99 −2.27 −1.00 −0.55 −0.20 −0.06
D1S1665 99.62 102.02 73,941,402 −999.99 −2.34 −1.04 −0.57 −0.20 −0.06
1Sex-average Kosambi cM map distances from the deCode genetic map [7].
2Sex-average Kosambi cM map distances from the Marshﬁeld genetic map [17].
3Sequence-based physical map distance in bases according to the Human Genome Project-Santa Cruz (http://genome.ucsc.edu/, Assembly: May 2004).
Table 3: Multipoint LOD score results between linked locus
identiﬁed in family and chromosome 1p34.2–p32.1 markers.
Marker Physical position Location LOD
ATA79C10 — 0.0000 −2.0630
D1S472 37,102,828 3.0940 nan
D1S186 37,900,316 5.1350 nan
D1S432 39,046,164 8.2290 −2.4708
D1S1598 40,011,183 9.2390 −0.0755
D1S2706 40,741,361 10.2490 −8.2103
D1S3721 41,395,560 11.2590 3.0063
D1S193 42,688,369 12.2690 3.2113
D1S2713 44,182,569 14.3100 3.3672
D1S2134 47,993,241 16.3510 3.4190
D1S1661 51,142,551 18.3920 3.4201
D1S2652 55,178,852 21.4860 3.3868
D1S2690 56,867,560 24.5800 3.2867
D1S2700 58,828,955 28.7490 2.8398
D1S2770 59,442,255 29.7590 1.3404
D1S1596 59,670,589 30.7690 nan
D1S2737 61,038,037 31.7800 −inf
D1S2788 61,568,857 34.8730 nan
D1S230 62,314,306 36.9140 −inf
D1S1648 73,125,563 43.3060 −inf
D1S1665 73,941,402 44.3160 nan
GATA152F05L 85,238,770 45.3260 nan
mutation at this point can be signiﬁcant (Figure 5(a)). The
evolutionary relationship between human, mouse, rat, and
rabbit were evaluated by phylogenetic analysis. The analysis
represents that the BSND of mouse and rat is closely related
to each other and shows homology with human and rabbit
(Figure 5(b)).
Our mutation (I12T) of BSND was generated by Swis-
spdbserverandwasanalyzedbyViewerlite.Thissubstitution
of isoleucine with threonine altered the bonding capacity
with other side chains as well as other interactors (Figure
6(a)-(b)).
According to STRING database, the physical and func-
tional interaction of BSND was very much signiﬁcant with
CLCNKB protein. Clinical assessment showed the reduced
chlorine level in all the aﬀected individuals. According
to further clinical assessments, renin level was at border
range in one aﬀected individual, so REN protein was also
selected to check the eﬀect of the respected mutation on
this protein. However, other interactors are COL7A1, ARL2,
CLCN5, KCNJ1, CASR, SLC12A1, SLC12A3, and CLCNKA
(Figure 7). Both the proteins were docked with HEX v
6.1, taking BSND as receptor and CLCNKB and REN as a
ligand.ThetotalenergyvaluecalculatedforBSND-CLCNKB
molecules was −229094.6 and BSND-REN was −1145.7.
However, the total energy value for the mutant (I12T) on
docking with CLCNKB was maximized to −218782.3 and
with REN was −1149.8. This values ﬂuctuation ultimately
results in reduced binding aﬃnity with CLCNKB and6 Journal of Biomedicine and Biotechnology
CC C C C C C C GGAA TT T TT T T T T GG G G GGGG N
(a)
CC C C C C C C G G AA TT T T T T T T T GG G G GGGG N N
(b)
CC C C C GGAA TT T T TT T T T T GG G GN GGGG N
(c)
Figure 2: Representative chromatogram generated by Big Dye Terminator, sequencing of translated exon1 of BSND gene indicating a T to
C transition at nucleotide 35 (35T > C) from an aﬀected female individual (VI-1) (a), a heterozygous carrier (VI-1) (b) and a normal male
individual (V-2) (c) of the family. The T to C transition at nucleotide position 35 results in isoleucine to threonine change at amino acid 12
(I12T). Arrows indicate the nucleotide change in the sequence.
(a) (b) (c)
Figure 3:ProteinmodelsofBSND(a)CLCNKB(b),andREN(c)generated bySAM T08andvisualizedbyRasmol(display =ribbon;colors
= group).Journal of Biomedicine and Biotechnology 7
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Figure 4: Rampage results of residues for protein model of human BSND protein (a) CLCNKB (b) and REN (c).
increased binding aﬃnity with REN and so may be the case
with other interacting proteins.
4. Discussion
Pathophysiological pathway leading from a speciﬁc mutation
to a speciﬁc phenotype has remained elusive in syndromic
as well as nonsyndromic hearing loss families. Individuals
with the same mutation can fall along a clinical spectrum
rangingfromasymptomatictoseverelyaﬀectedandcaneven
have completely diﬀerent diseases with diﬀerent mutation
in the same gene. Our results also support the ﬁndings of
Riazuddin et al. [19] that pathogenic mutation of BSND
gene can cause the nonsyndromic hearing loss. But there
are no subclinical renal metabolic changes in our family
as reported by Riazuddin et al. [19]. Renin level is at
boarder range only in one aﬀected individual, while renal
sonography ruled out the presence of nephrocalcinosis in
these aﬀected individuals. Nor have the aﬀected individuals
displayed problems with polydipsia, polyuria, nocturnal
enuresis, metabolic alkalosis, and hypocalciuria. It might be
possible that partial loss of function of barttin induced by
T12I allele cause only selectively hearing loss and appear to
have less pronounced eﬀects. However, the genotype does
not always predict the clinical phenotype, which varies both
within and between families carrying the mutation in the
same gene, implying the existence of other genetic and/or
environmental factors that inﬂuence phenotype. Several
disease-causing BSND mutations have been identiﬁed and
functionally analyzed. In all cases, there is a genotype-
phenotype relationship in that the level of function of
mutant barttin predicts the renal phenotype. Our results
support the relationship between missense BSND mutation
(I12T) and nonsyndromic hearing loss. It is a secondary
report that the BSND as causal gene in nonsyndromic
deafness.
The protein sequence of BSND is highly conserved in
closely related species of human, mouse, rat, and rabbit, and
it contains 2 putative transmembrane domain starting from
7t o2 6a m i n oa c i da n d3 1t o5 3a m i n oa c i d[ 20].
Bioinformatics analysis of mutation in BSND protein
suggest that isoleucine, a hydrophobic amino acid, is being
converted into threonine, a polar amino acid, which is more
susceptible to posttranslation modiﬁcations, aﬀecting the
quaternary structure of protein resulting in mutant pro-
tein.Journal of Biomedicine and Biotechnology 9
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Figure5:(a)ComparisonofconservedregionsofBSNDproteinbetweenhuman,mouse,rat,andrabbitbyusingUniportKBClustalW.Dark
region shows conserved amino acid sequence between species. (b) Phylogenetic analysis of BSND protein. It shows evolutionary relationship
between human, mouse, rat, and rabbit species.
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Figure 6: (a) Normal and mutated model (Il12T) of BSND are superimposed and visulized in Viewerlite. (b) Focused normal model is
yellow highlighted and displayed in stick format, and mutated is displayed in ball and stick format.
Barttin (BSND) is an accessory subunit that modi-
ﬁes protein stability, subcellular distribution, and voltage-
dependent gating of ClC-K chloride channels expressed in
renal and inner ear epithelia. ClC-K channels are double-
barreled channels with two identical protopores that may be
opened by individual or common gating processes [21].
Potassium (K+) secretion by strial marginal cells and
vestibular dark cells require Cl− to recycle in the basolateral
membrane via a major Cl− conductance. This Cl− con-
ductance is composed of the Cl− channels CLCNKA/BSND
and CLCNKB/BSND. Cl− channels CLCNKA/BSND and
CLCNKB/BSND consist of the pore-forming CLCNKA10 Journal of Biomedicine and Biotechnology
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Figure 7: The interactions of BSND with other functionally similar
proteins retrieved by STRING online database. CLCNKB showed
highest conﬁdence score, that is, 0.990 with BSND.
α-subunits and CLCNKB and the BSND β-subunit. Muta-
tions of BSND reduce channel conductivity and surface
expression [22].
Est´ evez et al. [2] proved that BSND protein is an essential
β subunit for CLCNKA and CLCNKB chloride channels,
with which it colocalizes in basolateral membranes of renal
tubules and of potassium-secreting epithelia of the inner
ear. Disease-causing mutations in either CLCNKB or BSND
compromise currents through heteromeric channels [2].
The CLCNKA and CLCNKB channels are members of
the ClC family, which comprises at least 9 mammalian chlo-
ride channels. Each is believed to have 12 transmembrane
domains and intracellular N and C termini. The prototype
of the family in torpedo is gated by both voltage and chloride
[23].
Docking results of both normal and mutant interaction
with CLCNKB suggested that there is a reduced binding
aﬃnity on mutation which may results the reduced down
regulatingorupregulatinginteractions;however,themutant
does not eﬀect the interaction with renin (REN). So, we can
conclude that the boarder range of renin level in one aﬀected
individual is not dependent upon this mutation.
IdentiﬁcationofmutationinBSNDgeneinmorefamilies
will give valuable insight into the genetic mechanisms
underlying nonsyndromic hearing disorder. This work is a
fundamentalstepinthebioinformaticsanalysisofBSNDand
provides basics for further analysis.
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